Virbac is the largest independent company worldwide exclusively dedicated to animal health and proud to support the Australian veterinary profession and pet owners. In 2021, Virbac launched STELFONTA, a breakthrough injectable non-surgical solution for mast cell tumours (MCTs) in dogs. STELFONTA is a targeted intratumoural treatment and a single treatment destroys the mast cell tumour completely in 75% of observed cases and 87% of tumours with up to two treatments. STELFONTA® contains tigilanol tiglate, a biologically active pharmaceutical compound extracted from the seed of the native Australian blushwood (Fontainea picrosperma) tree.